论文部分内容阅读
在万福生科的上市道路中,如果工商、税务、保荐、发审等环节有一个环节提出质疑,它也不可能如此顺利地上市。最近几个月最厉害的牛股当属万福生科。2014年12月复牌以来,累计上涨180%。事实上,当万福生科连续拉出五个“一字板”无量涨停时,已经有很多指责市场投机、市场不理性的舆论声浪,结果该股继续涨停。到了第9个涨停板时,公司停牌核查股价异动,十余天后以“无应披未披事项”复牌,复牌当天股价回落,结果之后继续上涨,当周三、周四更是涨
It is impossible for the listing of Wanfu Shengke to be marketed so smoothly if there is a link in business, taxation, sponsorship and issuance examination. In recent months, the most powerful Niugu shares Wanfu Health Sciences. Since the resumption of trading in December 2014, the cumulative increase of 180%. In fact, when Wanfook Sogo pulled out five consecutive “limitless” daily quotations, there have been many public opinions blaming the market for speculation and irrational market. As a result, the stock continued its daily limit. To the 9th daily limit, the company suspended the verification of stock price changes, more than ten days to “no cause for unwinding ” resumption of trading, the day the resumption of trading shares fell, the results continue to rise, when Wednesday, Thursday is up